Atrial fibrillation guidelines: 2012 updateUpdate incorporates new evidence on stroke prevention and rate and rhythm control. Drug News: June 2012Fampyra to improve walking speed in MS; Lodalis for hypercholestrerolemia; Saphris atypical antipsychotic; Other new products (Arzerra, Durela, Luxiq, Mozobil and Zelboraf); new generics, new indications, new dosage forms and Health Canada advisories. To go gently, or rage against the dying of the light? Contemplating the end of life, whether a patient’s or our own, inspires conflicting thoughts of logical inevitability and emotional resistance Dreams can come true, for hard worker The future for pharmacy is lined up for those who aspire to do great things for patients. Home health care: Innovation drives new ideas Some of the latest product trends showing up in home healthcare departments. Practice Issues: Best options for menstrual-related migraine Q. Which drugs are effective and safe for treatment or prevention of menstrual-related migraine? The Medical Post table of contents: June 5, 2012 print edition A section by section guide to content Go easy on statins in elderly stroke patients Tailored dosing needed to minimize side-effects How to preserve the brain while treating the bladder Some drugs kinder than others to the memory-impaired PRACTICE GEMS: It’s OK to accept gifts from patients First Previous 240 241 242 243 244 Next Last
